Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Understanding which risk dominates can guide your allocation decisions. This comparison highlights when inflation worry or market dips matter more.
28,524 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
In volatile markets, simplicity often wins. Here’s why I’m focusing on these only cryptocurrencies comfortable—Bitcoi...
As Trump meets with Xi, the U.S.-China relationship enters a peer-level phase. Security experts warn Beijing now sees...
As March moves unfold, the stock market today is colored by big auto headlines. Ford’s recall news sent ripples throu...
A fresh stake of roughly $4.5 million by a value-focused firm in Workiva raises questions about what comes next for W...
Eli Lilly dominates the GLP-1 space, but competition is heating up from outside and inside its own lineup. This guide...
Target unveiled a bold turnaround, but questions linger about what Target's Michael Fiddelke may be missing about eve...
As AI data centers surge, the choice between Constellation Energy and Vistra hinges on reliability, cost, and market ...
Parsons Corp faces a tough mix: a record backlog rising margins boost profitability, yet an upcoming policy and contr...
Viking Holdings has doubled its value in the past year, a standout move in the cruising sector. This article breaks d...
A fresh AI-driven forecast points XRP toward a multi-dollar climb in the next 90 days, backed by a leverage-driven se...
In mid-2026 market conditions test retirement plans built on dividend income. This piece weighs yield versus growth t...